Browse complete U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 Report

Browse all iData Research Market Research Reports

In 2009, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices was valued at $7.63 billion. This market includes

Over the forecast period, the CRM, electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced CRM devices. Within the cardiac rhythm management, electrophysiology and ablation markets, companies such as Boston Scientific, Biosense Webster, Medtronic, Philips, St. Jude Medical and Zoll lead the market, among many others.

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available.

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Original Source: Cardiac Rhythm Management Market, Electrophysiology and Ablation Devices Market